Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Normally, DNA is transcribed, or copied, to RNA and then translated to protein. Reverse transcriptase copies RNA back to DNA. Think of it as a car moving down a one-way street. Normally traffic only moves in one direction. But then, someone from out of town is driving the opposite way! Reverse transcriptase drives the opposite way in molecular processes in cells, converting RNA back to DNA.
Scope of the Report:
In the last several years, global market of Reverse Transcriptase developed smoothly, with an average growth rate of 4.6 %. In 2016, global revenue of Reverse Transcriptase is nearly 260 million USD; the actual production is about 570 liter.
The classification of Reverse Transcriptase includes MMLV Reverse Transcriptase and AMV Reverse Transcriptase; Moloney Murine Leukemia Virus (MMLV) Reverse Transcriptase is an RNA-directed DNA polymerase. This enzyme can synthesize a complementary DNA strand initiating from a primer using either RNA (cDNA synthesis) or single-stranded DNA as a template. And the sales proportion of MMLV Reverse Transcriptase in 2016 is about 80.9%.
Reverse Transcriptase can be used for PCR, Sequencing and Cloning, PCR was the largest application segment in 2016, and the proportion is about 59.4%. The application used in cloning with the fastest growth rate.
The worldwide market for Reverse Transcriptase is expected to grow at a CAGR of roughly 3.4% over the next five years, will reach 330 million US$ in 2024, from 280 million US$ in 2019, according to a new WMR study.
This report focuses on the Reverse Transcriptase in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
New England Biolabs
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
MMLV Reverse Transcriptase
AMV Reverse Transcriptase
Market Segment by Applications, can be divided into
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Reverse Transcriptase product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Reverse Transcriptase, with price, sales, revenue and global market share of Reverse Transcriptase in 2017 and 2018.
Chapter 3, the Reverse Transcriptase competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Reverse Transcriptase breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Reverse Transcriptase market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Reverse Transcriptase sales channel, distributors, customers, research findings and conclusion, appendix and data source.